Clinical trial
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
NCT00004842 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00004842 |
|---|---|
| Title | Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis |
| Official title | Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | Mayo Clinic |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cholangitis, Sclerosing, Liver Cirrhosis, Biliary |
| Intervention type | Drug |
| Interventions | budesonide |
| Enrollment | 22 |
| Start date | May 1, 1997 |
| Primary completion | Apr 1, 1999 |
| Completion | Apr 1, 1999 |
| First posted | Feb 25, 2000 |
| Last update posted | May 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: